Elevance Health Inc (NYSE: ELV) established initial surge of 0.15% at $533.73, before settling in for the price of $532.92 at the close. Taking a more long-term approach, ELV posted a 52-week range of $412.00-$539.11.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 13.24%. Meanwhile, its Annual Earning per share during the time was 12.18%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 12.46%. This publicly-traded company’s shares outstanding now amounts to $233.07 million, simultaneously with a float of $231.25 million. The organization now has a market capitalization sitting at $124.05 billion. At the time of writing, stock’s 50-day Moving Average stood at $510.37, while the 200-day Moving Average is $475.43.
Elevance Health Inc (ELV) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Elevance Health Inc industry. Elevance Health Inc’s current insider ownership accounts for 0.50%, in contrast to 91.78% institutional ownership. According to the most recent insider trade that took place on Mar 08 ’24, this organization’s EVP & President, Commercial sold 2,432 shares at the rate of 500.46, making the entire transaction reach 1,217,119 in total value, affecting insider ownership by 15,840. Preceding that transaction, on Mar 06 ’24, Company’s CAO & Controller sold 916 for 504.58, making the whole transaction’s value amount to 462,195. This particular insider is now the holder of 1,764 in total.
Elevance Health Inc (ELV) Earnings and Revenue Records
Elevance Health Inc’s EPS increase for this current 12-month fiscal period is 12.46% and is forecasted to reach 41.63 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 12.10% through the next 5 years, which can be compared against the 12.18% growth it accomplished over the previous five years trading on the market.
Elevance Health Inc (NYSE: ELV) Trading Performance Indicators
Let’s observe the current performance indicators for Elevance Health Inc (ELV). The Stock has managed to achieve an average true range (ATR) of 9.70. Alongside those numbers, its PE Ratio stands at $20.17, and its Beta score is 0.79. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.72. Similarly, its price to free cash flow for trailing twelve months is now 54.03.
In the same vein, ELV’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 26.46, a figure that is expected to reach 10.03 in the next quarter, and analysts are predicting that it will be 41.63 at the market close of one year from today.
Technical Analysis of Elevance Health Inc (ELV)
Now, what If we examine the latest scores posted by [Elevance Health Inc, ELV]. During the last 5-days, its volume was better the volume of 1.06 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 86.26% While, its Average True Range was 10.29.
Raw Stochastic average of Elevance Health Inc (ELV) in the period of the previous 100 days is set at 94.03%, which indicates a major rise in contrast to 87.99% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 17.80% that was higher than 15.73% volatility it exhibited in the past 100-days period.
